Prolonged release of antiepileptic drugs: Pharmaceutical strategies and impacts on patient’s quality of life
DOI:
https://doi.org/10.33448/rsd-v14i10.49666Keywords:
Epilepsy, Anticonvulsants, Drug Controlled Release, Medication Adherence.Abstract
Epilepsy is a chronic neurological disorder characterized by abnormal electrical discharges in the brain, which trigger seizures of varying intensity and duration. In addition to neurological manifestations, the condition can affect the patient’s emotional well-being and place a burden on family members and caregivers. Treatment is carried out through the use of antiepileptic drugs, which can be immediate-release or extended-release. Immediate-release medications require multiple daily doses and present greater variation in blood concentration, which may increase adverse effects. Extended-release drugs gradually release the active ingredient, maintaining stable plasma levels, reducing dosing frequency, and promoting treatment adherence. In this context, an integrative literature review was conducted to compare the efficacy, safety, and adherence between immediate-release and extended-release medications. It is concluded that extended-release antiepileptics show better outcomes regarding seizure control, treatment adherence, and patient quality of life, representing a promising strategy in the pharmacological management of epilepsy.
References
Ahmed, N., et al. (2018). "Retrospective analysis of the biopharmaceutics classification system and drug release profiles of extended-release formulations." European Journal of Pharmaceutical Sciences, 123, 1–8. https://doi.org/10.1016/j.ejps.2018.07.027
Anderson, G. D., & Saneto, R. P. (2015). Modified-release formulations of second-generation antiepileptic drugs: Pharmacokinetic and clinical aspects. CNS Drugs, 29(8), 669–681. https://doi.org/10.1007/s40263-015-0268-5
Arjona, J. C., Rubio, V., Darder, M., Aranda, P., Beltrán, M., Ruiz-Hitzky, E., et al. (2024). Influence of smectite clays’ pores volume on isoniazid adsorption and release. Applied Clay Science, 252, 107341. https://doi.org/10.1016/j.clay.2024.107341
Aucta Pharmaceuticals. (2022). Clinical pharmacology and biopharmaceutics review(s): NDA 216185, Lacosamide Extended-Release Capsules (Motpoly XR). U.S. Food and Drug Administration. https://www.accessdata.fda.gov
Associação Brasileira de Epilepsia. (2019). Manual: epilepsia e qualidade de vida. A:Care.
Bagheri, S., Hosseini, M., Sadeghnia, H. R., et al. (2019). Effect of probiotic supplementation on seizure activity and cognitive performance in PTZ-induced chemical kindling. Epilepsy & Behavior, 95, 43–50. https://doi.org/10.1016/j.yebeh.2019.02.037
Balestrini, S., Sisodiya, S. M., et al. (2021). The aetiologies of epilepsy. Epileptic Disorders, 23(1), 1–16. https://doi.org/10.1684/epd.2021.1255
Beghi, E. (2020). A epidemiologia da epilepsia. Neuroepidemiologia, 54(2), 185. https://doi.org/10.1159/000503831
Brandt, C., & De Maio, T. W. (2018). Formulações de medicamentos de liberação prolongada para o tratamento da epilepsia. Expert Opinion on Pharmacotherapy, 19(8), 843–850. https://doi.org/10.1080/14656566.2018.1465937
Brasil. Ministério da Saúde. (2018, junho 27). Portaria conjunta nº 17, de 21 de junho de 2018: Protocolo clínico e diretrizes terapêuticas – Epilepsia. Diário Oficial da União. https://www.in.gov.br/materia/-/asset_publisher/Kujrw0TZC2Mb/content/id/27391635/do1-2018-06-27-portaria-conjunta-n-17-de-21-de-junho-de-2018-27391620
Costa, L. L. O., Leite, L. H. P., Silva, M. S., et al. (2020). Atualização em epilepsia: Revisão de literatura. Revista Med, 99(2), 170. https://doi.org/10.11606/issn.1679-9836.v99i2p170-176
Devinsky, O., Vezzani, A., Najjar, S., De Lanerolle, N. C., & Rogawski, M. A. (2018). Epilepsy. Nature Reviews Disease Primers, 4(1), 18024. https://doi.org/10.1038/nrdp.2018.24
Ferreira, M. C., Silva, M. C., & Souza, A. L. (2022). Quality of life issues and occupational performance of persons with epilepsy. ResearchGate. Recuperado de https://www.researchgate.net/publication/221811605_Quality_of_life_issues_and_occupational_performance_of_persons_with_epilepsy
García-Villén, F., Rodríguez-Corrales, J., Ochoa-Gómez, J., Díez-Pascual, A. M., Arregui, F. J., Santamaría, J., et al. (2019). Montmorillonite-norfloxacin nanocomposite intended for healing of infected wounds. International Journal of Nanomedicine, 14, 5051–5060. https://doi.org/10.2147/IJN.S203013
Jain, K. K. (2020). An overview of drug delivery systems. In Methods in Molecular Biology (Vol. 2059, pp. 1–54). Springer.
https://doi.org/10.1007/978-1-4939-9798-5_1
Kandula, S., Challa, S., Shaik, A. B., Shaik, M. R., Hussain, M. D., Alzahrani, K., et al. (2023). Trends in smart drug delivery systems for targeting cancer cells. Materials Science and Engineering: B, 297, 116816. https://doi.org/10.1016/j.mseb.2023.116816
Kanner, A. M., Balabanov, A., Theodore, W. H., Schachter, S. C., Sperling, M. R., French, J. A., et al. (2018). Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy. Neurology, 91(2), e1–e9. https://doi.org/10.1212/WNL.0000000000005810
Kovalczuk, E. R. (2017). Desenvolvimento tecnológico de polímeros naturais aplicados à indústria farmacêutica [Dissertação de mestrado, Universidade Tecnológica Federal do Paraná]. Repositório Institucional UTFPR. https://repositorio.utfpr.edu.br/jspui/handle/1/3285
Krumholz, A., Wiebe, S., Gronseth, G. S., Cushman, M., So, Y. T., Sanchez, S. M., et al. (2015). Evidence-based guideline: Management of an unprovoked first seizure in adults—Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 84(16), 1705–1713. https://doi.org/10.1212/WNL.0000000000001487
Lee, S. K. (2019). Epilepsy in the elderly: Treatment and consideration of comorbid diseases. Journal of Epilepsy Research, 9(1), 27–35. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706648/
Liga Brasileira de Epilepsia. (2021). Tudo sobre epilepsia. https://www.epilepsia.org.br/tudo-sobre-epilepsia
Lüders, H., Noachtar, S., et al. (2019). Classification of paroxysmal events and the four-dimensional epilepsy classification system. Epileptic Disorders, 21(1), 1–29. https://doi.org/10.1684/epd.2019.1039
Martínez-Ferrández, C., Caraballo, R. H., Auvin, S., et al. (2019). Long-term prognosis of childhood absence epilepsy. Neurologia, 34(4), 224–228. https://doi.org/10.1016/j.nrl.2017.07.007
Maschio, M., Dinapoli, L., Mingoia, M., Sperati, F., Pace, A., & Fabi, A. (2018). Extended-release drug formulations for the treatment of epilepsy. Expert Opinion on Pharmacotherapy, 19(6), 591–598. https://doi.org/10.1080/14656566.2018.1462334
Mendes, F. R., Oliveira, P. F., & Carvalho, R. S. (2021). Pharmacokinetic advantages of extended-release antiepileptic drugs. Brazilian Journal of Clinical Pharmacology, 37(4), 455–466. https://doi.org/10.5935/bjcp.2021.1234
Ministério da Saúde. (2018). Protocolos clínicos e diretrizes terapêuticas: Epilepsia. Brasília, DF: Ministério da Saúde.
Oliveira, F. A. (2024). Resenha do livro A cor púrpura da epilepsia, de Carlos Scomazzon. Revista Brasileira de Educação Médica, 48(2), e052. https://doi.org/10.1590/1981-5271v48.2-2023-0244
Oliveira, J. P., Silva, M. A., & Santos, L. F. (2020). Comparative tolerability of carbamazepine XR and immediate-release formulations in epilepsy. Seizure, 80, 102–110. https://doi.org/10.1016/j.seizure.2020.05.004
Operto, F. F., Pastorino, G. M. G., Verrotti, A., Precenzano, F., Caggiano, R., Roccella, M., et al. (2023). Epilepsy and cognitive impairment in childhood and adolescence: A mini-review. Current Neuropharmacology, 21(8), 1646–1665. https://doi.org/10.2174/1570159X20666220706102708
Oshiro, C. A., & Castro, L. H. M. (2022). Cannabidiol and epilepsy in Brazil: A current review. Arquivos de Neuro-Psiquiatria, 80(5 Suppl 1), 182–192. https://doi.org/10.1590/0004-282X-anp-2022-0076
Pereira, A. S. et al. (2018). Metodologia da pesquisa científica. [e-book gratuito]. Santa Maria. Editora da UFSM.
Rachel, E. B., Brown, S., Smith, J., Johnson, M., Lee, T., Clark, P., et al. (2022). Toxicidade neurológica da carbamazepina no tratamento da neuralgia do trigêmeo. American Journal of Emergency Medicine, 55, 231.e3–231.e5. https://doi.org/10.1016/j.ajem.2022.06.012
Rozenzstrauch, A., & Kołtuniuk, A. (2022). The quality of life of children with epilepsy and the impact of the disease on the family functioning. International Journal of Environmental Research and Public Health, 19(4), 2277. https://doi.org/10.3390/ijerph19042277
Rosenow, F., Lüders, H., et al. (2020). Could the 2017 ILAE and the four-dimensional epilepsy classifications be merged to a new “Integrated Epilepsy Classification”? Epilepsy & Behavior, 78, 31–37. https://doi.org/10.1016/j.yebeh.2017.10.035
Santos, T. C. (2018). Desenvolvimento de sistemas matriciais de liberação modificada a partir de dispersões sólidas de ibuprofeno [Dissertação de mestrado, Universidade Federal Fluminense]. Repositório Institucional UFF. https://app.uff.br/riuff/handle/1/7470
Scheffer, I. E., Berkovic, S., Capovilla, G., et al. (2017). Classificação das epilepsias da ILAE: Relatório da Comissão de Classificação de Terminologia da ILAE. Epilepsia, 58(4), 512–521. https://doi.org/10.1111/epi.13709
Sheng, J., Liu, S., Qin, H., Li, B., & Zhang, X. (2018). Drug-resistant epilepsy and surgery. Current Neuropharmacology, 16(1), 17–28. https://doi.org/10.2174/1570159X15666170703110918
Silva, M. C., Santos, L. F., & Oliveira, J. P. (2019). Adesão ao tratamento com antiepilépticos de liberação prolongada: impacto na qualidade de vida e desempenho ocupacional. Revista Brasileira de Neurologia Clínica, 34(2), 123–134. https://doi.org/10.5935/0004-282X.20190023
Snyder, H. (2019). Revisão da literatura como metodologia de pesquisa: uma visão geral e diretrizes. Jornal de Pesquisa de Negócios, 104, 333-339. https://doi.org/10.1016/j.jbusres.2019.07.039.
Sperling, M. R., Doty, E. G., Hussein, Z., & Taft, D. R. (2023). Bioequivalence of extended-release and immediate-release lacosamide: Results of a randomized, open-label, multiple-dose, crossover study. Epilepsy & Behavior, 143, 109309. https://doi.org/10.1016/j.yebeh.2023.109309
Talwar, A., Estes, E., Aparasu, R., & Reddy, D. S. (2022). Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Experimental Neurology, 359, 114238. https://doi.org/10.1016/j.expneurol.2022.114238
Vale, G. F., Cunha, L. D. Q., Felipe, M. C. C., Assunção, L. F. A., Cantídio, M. O. R., Filho, F. M., et al. (2023). Neuroplasticidade e estimulação do nervo vago: Revisão integrativa dos avanços no tratamento da epilepsia. Brazilian Journal of Implantology and Health Sciences, 5(5), 2355–2374. https://doi.org/10.36557/2674-8169.2023v5n5p2355-2374
Wheeles, J. W., & Phelps, S. J. (2018). A clinician’s guide to oral extended-release drug delivery systems in epilepsy. Journal of Pediatric Pharmacology and Therapeutics, 23(4), 277–292. https://doi.org/10.5863/1551-6776-23.4.277
World Health Organization. (2023, February 9). Epilepsy. https://www.who.int/news-room/fact-sheets/detail/epilepsy
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Caroline de Souza Leite, Débora Aparecida Nepomuceno Leite, Vitória Moreira Francisco, Helineide Cristina Campos Brum
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
